Filter By Category
Archives
ASOPRISNIL ECAMATE
Generic Name: ASOPRISNIL ECAMATE
ABSTRACT -
Asoprisnil ecamate is an ecamate derivative of asoprisnil and belongs to the selective progesterone receptor modulator class. It was developed for gynecologic indications such as endometriosis, uterine fibroids, and menopausal symptoms, but clinical development was discontinued. It is not used as a routine approved medicine.
DOSAGE -
No approved dosing regimen exists. Past development used protocol-defined oral dosing. Use should be limited to authorized research contexts only.
SIDE EFFECTS–
- Possible or reported side effects may include:
- Headache
- Nausea
- Abdominal or pelvic pain
- Hot flushes
- Changes in menstrual bleeding
- Endometrial effects
- Breast discomfort
- Potential liver enzyme abnormalities
ALLERGIC REACTIONS -
Rash, hives, swelling, wheezing, severe dizziness, or anaphylaxis may indicate allergy.
DRUG INTERACTIONS-
Use caution with:
- Other hormonal agents
- CYP3A inhibitors/inducers where relevant
- Hepatotoxic drugs
- Anticoagulants when abnormal bleeding is present
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, and supplements they are using.
PREAUTIONS–
- Exclude pregnancy and assess reproductive history.
- Monitor uterine bleeding, endometrial changes, and liver function if studied.
- Avoid unsupervised use.
WARNINGS –
- Discontinued investigational agent; not for clinical substitution.
- Serious bleeding, jaundice, or hypersensitivity requires urgent care.
- Keep out of reach of children.
- In case of overdose, severe reaction, or clinical deterioration, seek immediate medical attention.



. Developed by